Clinical Trials Directory

Trials / Completed

CompletedNCT01427491

Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers

A Prospective, Multi-center, Randomized, Comparative Clinical Study to Compare Aquacel® Ag vs. Mepilex® Border Ag to Manage Bioburden in Leg Ulcers.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
18 (actual)
Sponsor
ConvaTec Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the ability of Aquacel® Ag and Mepilex® Border Ag to manage bioburden in leg ulcers over a two week study period.

Conditions

Interventions

TypeNameDescription
DEVICEAquacel® AgDressing will be changed during the clinic visit on day 3, 7 and 14. In between the clinic visits the dressing should be changed when needed depending on the clinical condition of the wound and the volume of exudate.
DEVICEMepilex® Border AgDressing will be changed during the clinic visit on day 3, 7 and 14. In between the clinic visits the dressing should be changed when needed depending on the clinical condition of the wound and the volume of exudate.

Timeline

Start date
2011-08-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2011-09-01
Last updated
2013-07-30

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01427491. Inclusion in this directory is not an endorsement.